Store ZITHROMAX Film-Coated Tablets at controlled room temperature (15-30°C).
Powder for Oral Suspension:
Dry powder: Store at controlled room temperature (15-30°C).
Reconstituted suspension: Store between 5°C and 30°C. Discard unused portion after 10 days.
ZITHROMAX for Injection:
Dry powder: Store at controlled room temperature (15-30°C).
Diluted solution: Stable for 24 hours at or below 30°C, or for 72 hoursif stored under refrigeration (2-8°C). For single-use only. Discard any unused portion after use.
Store ZITHROMAX Film-Coated Tablets at controlled room temperature (15-30°C).
Powder for Oral Suspension:
Dry powder: Store at controlled room temperature (15-30°C).
Reconstituted suspension: Store between 5°C and 30°C. Discard unused portion after 10 days.
ZITHROMAX for Injection:
Dry powder: Store at controlled room temperature (15-30°C).
Diluted solution: Stable for 24 hours at or below 30°C, or for 72 hoursif stored under refrigeration (2-8°C). For single-use only. Discard any unused portion after use.
*Contact Medical Information. 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Contact Pfizer Safety to report an adverse event, side effect or concern about the quality of a Pfizer product: 1 866 723-7111.
To report an adverse event related to COMIRNATY, and you are not part of a clinical trial* for this product, click the link below to submit your information:
*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
You may also contact the Canada Vigilance Program directly to report adverse events or product quality concerns at 1-866-234-2345 or www.healthcanada.gc.ca/medeffect.